Cargando…

Mixed muco-cutaneous pemphigoid: Clinical and immunological features of 15 cases

INTRODUCTION: We describe a series of patients whose auto-immune bullous skin disease (AIBD) of the dermal-epidermal junction (DEJ) was characterized by clinical, immunological and ultrastructural features intermediate between bullous pemphigoid (BP) and mucous membrane pemphigoid (MMP), and a recal...

Descripción completa

Detalles Bibliográficos
Autores principales: Janela, Raphaël, Ishii, Norito, Castel, Marion, Jouen, Fabienne, Cellier, Lucie, Courville, Philippe, Joly, Pascal, Hébert, Vivien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10050733/
https://www.ncbi.nlm.nih.gov/pubmed/37006294
http://dx.doi.org/10.3389/fimmu.2023.1134720
_version_ 1785014698224123904
author Janela, Raphaël
Ishii, Norito
Castel, Marion
Jouen, Fabienne
Cellier, Lucie
Courville, Philippe
Joly, Pascal
Hébert, Vivien
author_facet Janela, Raphaël
Ishii, Norito
Castel, Marion
Jouen, Fabienne
Cellier, Lucie
Courville, Philippe
Joly, Pascal
Hébert, Vivien
author_sort Janela, Raphaël
collection PubMed
description INTRODUCTION: We describe a series of patients whose auto-immune bullous skin disease (AIBD) of the dermal-epidermal junction (DEJ) was characterized by clinical, immunological and ultrastructural features intermediate between bullous pemphigoid (BP) and mucous membrane pemphigoid (MMP), and a recalcitrant course. PATIENTS AND METHODS: From the database of the French reference centre for AIBD, we screened all the patients who were referred for an AIBD of the DEJ with a mucosal involvement, who neither met the diagnostic criteria for the diagnosis of BP, nor were typical of MMP. Sera were analysed by NC16A-ELISA and immunobloting against the C-terminal and LAD-1 parts of BP180. Skin biopsies were studied by direct immunoelectron microscopy (IEM). RESULTS: Fifteen patients (4 males, 11 females) of mean age 70.8 ± 11.8 years were included. The mucosal involvement was localized in oral cavity in all cases and in pharyngeal/laryngeal or genital area in 8 (53%), and 6 patients (40%), respectively. No patient had ocular involvement, nor atrophic or fibrosing scars. All patients had extensive skin lesions (mean BPDAI score =65.9 ± 24.4), which predominated on the upper body part. Direct IEM performed on 8 patients showed IgG deposits on the lamina lucida in all cases, and the lamina densa in 5 cases. All sera recognized NC16A, while none recognized BP-230 in ELISA. 10 out of the 13 tested sera (76.9%) contained IgG which recognized the C-terminal domain of BP180 and 10 sera (76.9%) the LAD-1 domain of BP180. Patients poorly responded to super potent topical corticosteroids and were treated with oral corticosteroids ± immunosuppressant in 13 cases (86.6%). CONCLUSION: This mixed muco-cutaneous pemphigoid differs from BP by the younger age of patients, multiple mucosae involvement, circulating antibodies against both the C- and N-terminal part of BP180, and very poor response to topical CS. It differs from MMP by extensive inflammatory skin lesions, absence of ocular involvement and atrophic/fibrosing scars.
format Online
Article
Text
id pubmed-10050733
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-100507332023-03-30 Mixed muco-cutaneous pemphigoid: Clinical and immunological features of 15 cases Janela, Raphaël Ishii, Norito Castel, Marion Jouen, Fabienne Cellier, Lucie Courville, Philippe Joly, Pascal Hébert, Vivien Front Immunol Immunology INTRODUCTION: We describe a series of patients whose auto-immune bullous skin disease (AIBD) of the dermal-epidermal junction (DEJ) was characterized by clinical, immunological and ultrastructural features intermediate between bullous pemphigoid (BP) and mucous membrane pemphigoid (MMP), and a recalcitrant course. PATIENTS AND METHODS: From the database of the French reference centre for AIBD, we screened all the patients who were referred for an AIBD of the DEJ with a mucosal involvement, who neither met the diagnostic criteria for the diagnosis of BP, nor were typical of MMP. Sera were analysed by NC16A-ELISA and immunobloting against the C-terminal and LAD-1 parts of BP180. Skin biopsies were studied by direct immunoelectron microscopy (IEM). RESULTS: Fifteen patients (4 males, 11 females) of mean age 70.8 ± 11.8 years were included. The mucosal involvement was localized in oral cavity in all cases and in pharyngeal/laryngeal or genital area in 8 (53%), and 6 patients (40%), respectively. No patient had ocular involvement, nor atrophic or fibrosing scars. All patients had extensive skin lesions (mean BPDAI score =65.9 ± 24.4), which predominated on the upper body part. Direct IEM performed on 8 patients showed IgG deposits on the lamina lucida in all cases, and the lamina densa in 5 cases. All sera recognized NC16A, while none recognized BP-230 in ELISA. 10 out of the 13 tested sera (76.9%) contained IgG which recognized the C-terminal domain of BP180 and 10 sera (76.9%) the LAD-1 domain of BP180. Patients poorly responded to super potent topical corticosteroids and were treated with oral corticosteroids ± immunosuppressant in 13 cases (86.6%). CONCLUSION: This mixed muco-cutaneous pemphigoid differs from BP by the younger age of patients, multiple mucosae involvement, circulating antibodies against both the C- and N-terminal part of BP180, and very poor response to topical CS. It differs from MMP by extensive inflammatory skin lesions, absence of ocular involvement and atrophic/fibrosing scars. Frontiers Media S.A. 2023-03-15 /pmc/articles/PMC10050733/ /pubmed/37006294 http://dx.doi.org/10.3389/fimmu.2023.1134720 Text en Copyright © 2023 Janela, Ishii, Castel, Jouen, Cellier, Courville, Joly and Hébert https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Janela, Raphaël
Ishii, Norito
Castel, Marion
Jouen, Fabienne
Cellier, Lucie
Courville, Philippe
Joly, Pascal
Hébert, Vivien
Mixed muco-cutaneous pemphigoid: Clinical and immunological features of 15 cases
title Mixed muco-cutaneous pemphigoid: Clinical and immunological features of 15 cases
title_full Mixed muco-cutaneous pemphigoid: Clinical and immunological features of 15 cases
title_fullStr Mixed muco-cutaneous pemphigoid: Clinical and immunological features of 15 cases
title_full_unstemmed Mixed muco-cutaneous pemphigoid: Clinical and immunological features of 15 cases
title_short Mixed muco-cutaneous pemphigoid: Clinical and immunological features of 15 cases
title_sort mixed muco-cutaneous pemphigoid: clinical and immunological features of 15 cases
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10050733/
https://www.ncbi.nlm.nih.gov/pubmed/37006294
http://dx.doi.org/10.3389/fimmu.2023.1134720
work_keys_str_mv AT janelaraphael mixedmucocutaneouspemphigoidclinicalandimmunologicalfeaturesof15cases
AT ishiinorito mixedmucocutaneouspemphigoidclinicalandimmunologicalfeaturesof15cases
AT castelmarion mixedmucocutaneouspemphigoidclinicalandimmunologicalfeaturesof15cases
AT jouenfabienne mixedmucocutaneouspemphigoidclinicalandimmunologicalfeaturesof15cases
AT cellierlucie mixedmucocutaneouspemphigoidclinicalandimmunologicalfeaturesof15cases
AT courvillephilippe mixedmucocutaneouspemphigoidclinicalandimmunologicalfeaturesof15cases
AT jolypascal mixedmucocutaneouspemphigoidclinicalandimmunologicalfeaturesof15cases
AT hebertvivien mixedmucocutaneouspemphigoidclinicalandimmunologicalfeaturesof15cases